Phase II Iressa + Irradiation Followed by Chemo in NSCLC

Clinical trial NCT00333294 · COMPLETED

Trial details

NCT number: NCT00333294
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2004-09-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.